Published in Hospital and Nursing Home Week, April 15th, 2004
Carlo Croce, MD, director of the Kimmel Cancer Institute and Kimmel Cancer Center at the Thomas Jefferson University, and member of the CorCell Scientific and Medical Advisory Board in Philadelphia, Pennsylvania, suggests there will be a long time before any patients could be treated with cloned embryonic cells.
There are a multitude of problems that must be addressed before this event could take place. For example: during the Korean experiments, the researchers required 242 egg cells which produced 30 blastocysts - a success rate of only 10%. While...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.